Skip to content

Enabling Next Gen Biologics

At iBio, we’re enabling the next generation of biologics with the FastPharming® System for high-quality, eco-friendly recombinant protein production. A wide array of proteins can be efficiently expressed using our Nicotiana benthamiana plants and readily scaled-up for high volume production in our 130,000-square-foot FastPharming Facility in Bryan, Texas.

We’re putting these capabilities to work for our clients via our array of contract development and manufacturing services, as well as deploying them for the advancement of our own pipeline of therapeutics, vaccines, and products for research & bioprocessing applications.  Plus, with our Glycaneering Development Service, we have greater control over protein glycoforms, including the ability to remove fucose to create more potent monoclonal antibody therapeutics.

Our innovative, hard-working teams are combining our technologies and capabilities to address unmet medical needs in human health and veterinary medicine, while enabling our clients to advance their biopharmaceuticals and 3D-bioprinted/tissue engineered products through the clinic and to market.

FastPharming Advantages

  • Faster: Greater speed-to-clinic by shaving months off of traditional mammalian-cell development times
  • Safer: Less contamination risk since mammalian viruses and prions can’t grow in plants
  • Eco-Friendly: Avoids plastic single-use disposables widely used with mammalian-cell biologics production
  • Easier: Avoids scaling issues moving to large bioreactors – just grow more plants
  • Better: Powerful, proprietary glycosylation controls for better performance and higher quality

Learn More

Technology Applications

The FastPharming platform produces a variety of recombinant products including:
  • Biobetter and biosimilar antibodies
  • Antigens for subunit vaccine design
  • Virus-like particles (VLP)
  • Lysosomal enzymes
  • Blood factors and cytokines
  • Scaffolds, maturogens and materials for 3D Bioprinting and biofabrication

Fast, Full-Service CDMO

iBio is a full-service biologics CDMO equipped to take you from pre-clinical development through regulatory approval, to commercial product launch.

Learn More

Commitment to Quality

The Quality Department at iBio is staffed with highly motivated and skilled professionals who are knowledgeable in biologics development and manufacturing.  Key elements of our quality program include:

  • A fully integrated Quality Management System (QMS)
  • Robust process/product control systems
  • Comprehensive compliance programs

iBio’s quality systems are designed to comply with cGMP’s as well as ex-US regulatory requirements.

iBio’s Quality Policy

iBio is dedicated to maintaining the effectiveness of the quality system through robust process management and quality oversight, compliance with all applicable regulatory requirements, and meeting or exceeding customer expectations by delivering quality products and services.

Our Team


  • CC-Pharming
  • The Texas A&M AgriLife
  • The Texas A&M University System
  • SAFI
  • EdgePoint AI
  • IDRI
  • RubrYc Therapeutics
    RubrYc Therapeutics
  • FairJourney Biologics
    FairJourney Biologics